🇺🇸 FDA
Patent

US 8927718

Fused heterocyclic ring derivative and use thereof

granted A61PA61P35/00A61P43/00

Quick answer

US patent 8927718 (Fused heterocyclic ring derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00, A61P43/00